These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 16084158
1. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II). Konstam MA, Neaton JD, Poole-Wilson PA, Pitt B, Segal R, Sharma D, Dasbach EJ, Carides GW, Dickstein K, Riegger G, Camm AJ, Martinez FA, Bradstreet DC, Ikeda LS, Santoro EP, ELITE II Investigators. Am Heart J; 2005 Jul; 150(1):123-31. PubMed ID: 16084158 [Abstract] [Full Text] [Related]
2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [Abstract] [Full Text] [Related]
10. [ELITE II. AT1-blockers not better, but more tolerable than ACE-inhibitors]. Berger D. Internist (Berl); 2000 Jan; 41(1):A37. PubMed ID: 10712087 [No Abstract] [Full Text] [Related]
13. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction. Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C. Clin Ther; 2008 Jan; 30 Pt 2():2217-27. PubMed ID: 19281916 [Abstract] [Full Text] [Related]